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Abstract
Background: The human platelet alloantigen system HPA-1 in the Egyptian population was
examined by polymerase chain reaction using sequence-specific primers (PCR-SSP). The objectives
of this study were to evaluate the allele frequency of HPA-1a and -1b in healthy Egyptian individuals
and compare these with the international literature. Human platelet antigen (HPA) systems are
associated with alloimmunization and organ transplantation rejection as well as the development
of cardiovascular disease. Of the various HPA systems, HPA-1 specifically has been considered to
be the most important antigenic system implicated in the Caucasian population. No study has yet
examined this system in the Egyptian populations, however. We therefore investigated the allele
frequency of the HPA-1 system in the Egyptian population.
Findings: To determine the allele frequency of the HPA-1a and -1b, we tested genomic DNAs
from 206 healthy, unrelated Egyptian individuals using PCR-SSP. Our results showed that the 1a/1a
genotype was the most predominant (59.22%) followed by 1a/1b (34.95%) and 1b/1b (5.83%) with
allele frequencies for 1a and 1b of 0.77 and 0.23, respectively, in the population.
Conclusion: As compared with other geographic groups, a relatively high allele frequency of the
HPA-1b in the Egyptian population may indicate a higher risk of alloimmunization. This study is the
first to investigate the allele frequency of the HPA-1 system in the Egyptian population and serves
as an outline for future clinical research associated with platelet disorders in this group.

Background
The human platelet antigens (HPA) systems derive from
the single base pair substitution in the encoding genes of
platelet membrane glycoproteins (GP). The GP variants
resulting from amino acid substitutions are involved in
the rate of alloimmunization to platelet-specific antigens.
Subsequently, the alloimmunization can induce neonatal
alloimmune thrombocytopenia (NAIT) [1], post-transfusion purpura (PTP), or platelet transfusion refractoriness

(PTR) [2]. Therefore, accurate donor compatibility for
platelet transfusions is extremely important. HPA systems
are not only associated with organ transplantation rejection [3] and cardiovascular disease [4], but are also frequently assessed in general population studies. The
molecular basis of the biallelic polymorphisms of all HPA
systems (i.e. HPA-1, 2, -3, -4, -5, -15) is linked to platelet
GP variants. The major GPs (GPIIb, GPIIIa, GPIb, and
GPIa) generated by single amino acid substitutions are
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associated with various HPAs [5]. The presence of leucine
or proline at position 33 of the GPIIIa results in two HPA1a or HPA-1b antigens, respectively [6]. Therefore, molecular DNA-based analysis has been preferred for the HPA
genotyping.
Recent studies of population genetics have reported that
there is a heterogeneous diversity of HPA genotypes in different geographic groups. However, these studies have
largely been performed in Asian, European, and North
American populations [7-9]. Among Arabian populations, Egyptians are among the most centrally located to
Africa, Europe, and Asia. This fact resulted in Egypt's varied cultural history and its population is a diverse genetic
amalgam. To date, the HPA-1 polymorphisms have not
been assessed in the Egyptian population. The aim of this
study was to investigate the allele frequencies of HPA-1
and estimate the frequency of the 1a and 1b alleles among
the healthy Egyptian population.

Methods
Samples and DNA extraction
Blood samples were collected from 206 unrelated, healthy
Egyptians from Ismailia under institutionally approved
internal review board protocols with informed consent.
DNA was prepared from blood leukocytes by standard
methods [10]. The genotypes of HPA-1 system were determined using the polymerase chain reaction sequence-specific primers (PCR-SSP) method designed by Skogen et al.
and the SSPs were used to discriminate between the alleles
encoding the six major HPAs in a series of patients and
normal blood donors [11]. The thermocycler program
consists of an initial step of 94°C for 5 min, followed by
32 cycles of 94°C for 30 s, 65°C for 60 s, 72°C for 60 s,
and a final extension step of 72°C for 10 min. The PCR
products (15 ul) were subjected to gel electrophoresis on
standard 1.5% agarose gel containing 0.5 ug per ml of
ethidium bromide. The typing results were examined
under UV light transillumination. For each sample, it was
possible to determine the absence or presence of the two
alleles, 1a and 1b. Individuals are, therefore, genotypically
classified as 1a/1a, 1a/1b or 1b/1b.

Statistical analysis
Statistical analysis was performed using SPSS version 15
statistical package for windows. Allele and genotype frequencies were calculated by direct counting; Hardy-Weinberg equilibrium was assessed by an exact test provided by
the Arlequin program [12].

Results and discussion
The genotype and allele frequencies of HPA-1 system in
the Egyptian population are shown in Table 1. The study
population was found to be in Hardy-Weinberg equilibrium. The 1a/1a genotype is the most predominant
(59.22%) followed by 1a/1b (34.95%) and 1b/1b
(5.83%) (Table 1). In these 206 unrelated Egyptian individuals, the allele frequencies of 1a and 1b were calculated
to be 0.77 and 0.23, respectively. Table 2 describes the
allele frequencies at the HPA-1 with those previously
reported in other ethnic populations.
The allele frequencies of several of HPAs vary among different ethnic groups and their prevalence in a given population is a major determinant for the prevalence of HPA
alloimmunization and its clinical associated entities:
NAIT, PTP, PTR, post-transfusion passive alloimmune
thrombocytopenia,
and
transplantation-associated
alloimmune thrombocytopenia [13]. In one study, HPA1 antibodies were found to be present in 80% of patients
with NAIT, and the HPA-1a allele was concluded to be a
factor contributing to the disease [1]. Although alloantibodies against the HPA-1 are frequently implicated in
alloimmunization, the detection of HPA-1 is not recommended in African-American and Asian geographic
groups because of the low allele frequency of the HPA-1b
allele in these populations [8]. As shown in Table 2, the
allele frequency of HPA-1b for the African-American population is in fact lower than that for the Caucasian-American population (0.080 vs. 0.110). Furthermore,
antibodies against HPA-1 antigens were extremely rare in
Japanese patients with NAIT or refractoriness to platelet
transfusion, with an allele frequency of 0.002 for antiHPA-1b [14]. Halle et al. recently studied four different
sub-Saharan African populations (Beninese, Camerooni-

Table 1: Distribution of the various HPA-1 genotypes and gene frequencies among the Egyptian population.

HPA-1 Allele Frequency

Heterozygosity Frequency

N

HPA-1 Genotype

Number Observed
(Percentage)

1a

1b

Observed

Expected

206

1a/1a

122 (59.22)

0.767

0.233

0.350

0.357

1a/1b
1b/1b

72 (34.95)
12 (5.83)

Total Chi2 goodness of
fit test

0.101
(p = 0.7505)
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Table 2: Allele frequencies of HPA-1a and -1b in different
populations.

Population [reference]

Berber Moroccan [22]
Tunisian [23]
Bahraini [21]
Egyptian [this study]
Lebanese [24]
Danish [28]
French [26]
Spanish [27]
Austrian [7]
Polish [25]
Caucasian-American [8]
African-American [8]
Korean [9]
Japanese [14]
Amazon Indian [29]

Allele Frequency (%)
1a

1b

0.748
0.750
0.760
0.767
0.810
0.831
0.848
0.851
0.852
0.874
0.890
0.920
0.988
0.998
1.000

0.252
0.250
0.240
0.233
0.190
0.169
0.152
0.149
0.148
0.126
0.110
0.080
0.012
0.002
0.000

N

110
90
194
206
205
557
800
500
911
135
100
100
200
331
95

ans, Congolese, and Pygmies) and the allele HPA-1b was
reported to be somewhat low by contrast to other HPA
systems (HPA-2, -3, -4, -5, -15) [15]. By contrast, the allele
frequency of HPA-1b in Aka Pygmy populations was
0.000, a result that might explain the low risk of alloimmunization anti-HPA-1a compared with Caucasian populations [15].
An increasing number of population genetic studies have
been conducted to assess the effect of the HPA-1 system
on the risk of developing cardiovascular disease or myocardial infarction (MI). However, the data obtained to
date contained contradictions, and the correlation is still
under debate. Weiss et al. reported that HPA-1b increases
the risk of MI or unstable angina in Caucasian populations [16]. The ratio of developing MI or unstable angina
between patients with the HPA-1a/1a genotype and those
with either the HPA-1a/1b or the 1b/1b genotype was
found to be 6:2 [16]. Other studies highlighted the effect
of HPA-1 in coronary artery disease and showed a positive
correlation in the same age group [17], as well as in the
Caucasian population [18]. By contrast, studies of the Japanese [19] and Korean [20] populations failed to demonstrate a significant correlation between HPA-1 and the risk
of coronary artery disease or MI. Even in Caucasian populations, many studies did not detect any relationship [18].
As shown in Table 2, the Egyptians show an HPA-1 allele
frequency that is similar to previously studied Arab populations (Tunisian, Moroccan, and Bahraini) except for the
Lebanese [21-24]. The Egyptians have a slightly higher frequency of HPA-1b when compared to the Caucasian population (European and White American) [8,25-28]. The
Berbers (Morocco) have been shown to have the highest

frequency for the HPA-1b allele [22]. This is in contrast to
the Asian populations and, in particular, the Amazon
Indian population, which was shown to have total
absence of the HPA-1b allele [29]. The relatively high
allele frequency of the HPA-1b in the Egyptian population
suggests that this ethnic group has a higher risk of alloimmunization. This is the first to study the allele frequency
of the HPA-1 system in this population and, to date, there
are no data available on the effect of HPA-1 on the risk of
developing alloimmunization, cardiovascular disease, or
MI among Egyptian patients. Although the prevalence of
NAIT, PTP, and PTR has not been established in the Egyptian population yet, the detection of HPA alloantibodies
before any transfusion or pregnancy should be recommended to prevent any clinical condition, especially
when there is a positive family history of cardiovascular
disease. This is because platelet hyperactivity caused by a
conformational change in the GP receptors on the platelet
surface may confer an increased risk for cardiovascular
disease. The authors believe that this study will serve as a
baseline for future clinical research associated with platelet disorders or cardiovascular diseases associated with the
Egyptian population.
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